Bachem, founded 1971 and operating worldwide, offers services for the pharma and biotech industry by manufacturing peptides and oligonucleotides as active pharmaceutical ingredients (APIs) and by providing innovative biochemicals for research. Bachem is the number one worldwide in the peptide business and can take profit from the more and more complex structures of molecules and new routes of administration developed for innovative targeted therapies.